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Elevation of aspartate aminotransferase predicts mortality after coronary artery bypass grafting T. Wang 1* , R. Stewart 1,2 , T. Ramanathan 1 , G. Gamble 2 , H. White 1,2 1 Green Lane Cardiovascular Service, Auckland City Hospital, Auckland 2 Department of Medicine, University of Auckland, Auckland * Corresponding author.
Background: Cardiac troponins are the recommended biomarkers for diagnosing myocardial infarction (MI). Since troponins have become widely available, the roles of other less specific biomarkers have been seldom studied. Aspartate aminotransferase (AST) not only correlates with MI, but also with liver injury due to ischaemia or congestion. We assessed whether post-operative AST levels were associated with adverse outcomes after contemporary coronary artery bypass grafting (CABG).
Methods: Patients undergoing isolated CABG during July 2010-June 2012 at Auckland City Hospital were included if they had a post-operative AST measurement within 48 hours (n = 805), and their prognostic utility for adverse outcomes assessed by receiver-operative characteristics and multivariate analyses.
Results: Median post-operative AST levels was 37U/L (lower quartile 30, upper quartile 48). C-statistics and 95% confidence interval for AST at predicting 30-day mortality was 0.762 (0.609-0.915), with the optimal cutpoint of 70U/L giving 58.3% sensitivity and 90.7% specificity. AST also detected composite morbidity 0.573 (0.518-0.628), ventila-tion>24 hours 0.615 (0.555-0.676), and peri-operative myocardial infarction 0.594 (0.524-0.664) defined according to the universal definition, but not mortality during follow-up 0.580 (0.491-0.670). In multivariate analysis, AST per 10U/L increase remained an independent predictor of 30-day mortality odds ratio 1.14 (1.04-1.24), mortality during follow-up hazards ratio 1.08 (1.00-1.15) but not composite morbidity odds ratio 1.03 (0.962-1.10). Independent predictors of AST>90U/L included female sex, unstable angina and operation time.
Conclusions: AST levels within 48 hours after CABG independently predict mortality and morbidity. Although AST rise is not specific to myocardial necrosis, it remains a useful prognostic tool in cardiac surgery. Background: Eosinophilic myocarditis (EM) is a rare and potentially fatal entity characterised by inflammation with infiltrating eosinophils. Limited published data are available documenting presentation, management and prognosis. We report these data in a series of patients with EM treated at Auckland City Hospital.
Methods: All patients diagnosed with EM at our institution during January 2010-August 2013 were identified from the electronic laboratory and haematology databases, and clinical characteristics and outcomes reviewed.
Results: Seven patients, four male and median age 41 (range 1.5-62) years were identified. Median follow-up was 18 (range 0.2-33) months. The peripheral eosinophil count was abnormal in 5 and median peak levels were 2.1 (0.22-17.7) x10^9/L. Cardiac biopsy was diagnostic of EM in 5 of 6 cases performed, while eosinophilia of bone marrow was found in 3 of 4 performed. Inotropic support for cardiogenic shock was required in 3 cases. Corticosteroids were commenced in 5 patients, and in 3 cases this was initially given intravenously. Corticosteroids achieved normalisation of eosinophil count in 4 patients, and in 2 of 3 patients this led to improvement in LV function to normal, while the remaining patient died in hospital. Two patients developed ventricular arrhythmia also leading to one in-hospital death, and one death at 2 years after initial diagnosis.
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Conclusions: Our findings suggest endomyocardial biopsy has good diagnostic yield for EM, corticosteroid is an effective first-line treatment, and ventricular arrhythmia is an important cause of mortality. Multi-centre collaboration to obtain a larger data set for this rare condition is warranted. Background: Dual anterograde and retrograde cardioplegia delivery, warm induction and hotshot delivery had previously been shown to confer myocardial protection, but have not been studied for over a decade. High-sensitivity troponins (hs-Tn) are now the recommended biomarkers for assessing myocardial necrosis. We compared the degree of hs-TnT release and outcomes of aortic valve replacement (AVR) by these cardioplegia techniques.
Methods: All patients undergoing isolated AVR during July 2010-December 2012 were studied, categorised by cardioplegia techniques for analyses Results: Amongst 219 patients followed-up for 1.8+/-0.8 days, 14.7% (32), 63.3% (138) and 22.0% (48) had anterograde, retrograde and dual cardioplegia delivery route respectively; 88.1% (193) and 11.9% (26) had cool and warm induction, and 77.6% (171) had hotshot delivered. Dual anterograde and retrograde cardioplegia was independently associated with Maori or Pacific ethnicity (P = 0.006), while hotshot delivery was independently associated with cardiopulmonary bypass time (P = 0.001). None of the cardioplegia techniques was associated with greater hs-TnT release post-operatively. In multivariate analyses of outcomes, hotshot delivery was independently associated lower operative mortality odds ratio 0.070, 95% confidence interval (95%CI) 0.006-0.781, P = 0.031, greater survival during follow-up hazards ratio 0.214, 95%CI 0.064-0.716, P = 0.012, and a trend towards lower rate of perioperative myocardial infarction (P = 0.096). Warm induction was associated with a trend towards higher rates of prolonged ventilation>24 hours (P = 0.091).
Conclusions: Hotshot delivery was independently associated with reduced operative, follow-up mortality and a trend towards lower rates of perioperative myocardial infarction. None of the cardioplegia techniques were associated with greater hs-TnT release or composite morbidity. http://dx.doi.org/10. 1016/j.hlc.2014.04.246 
